<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1205</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15558593</PubmedId>
            <Abstract>Virus-specific CD8+ T cells play a major role in antiviral immune defenses; their significance in the transplant setting, however, is unclear. In the present study, we asked whether hepatitis C virus (HCV)-specific CD8+ T cells were detectable in the presence of an immunosuppressive treatment and whether the HCV-specific CD8+ T cell response correlates with treatment outcome in patients who receive interferon (IFN)-alpha / ribavirin therapy after orthotopic liver transplantation (OLTx). Liver- and blood-derived T cell lines of 21 patients after OLTx were studied before, at the end of, and after antiviral treatment. Virus-specific IFN-gamma production in response to a panel of previously identified HCV-specific epitopes restricted by the human leukocyte antigen (HLA) class I molecules A2, A3, B7, B35, and B44 of structural and nonstructural HCV protein was determined by enzyme-linked immunospot (ELISPOT) assay. Before treatment, only low numbers of HCV-specific CD8+ T cells were detectable. In 6 patients with a sustained virological response, a significant, multispecific, and sustained CD8+ T cell response was detectable, which was mainly found in the peripheral blood. Nonresponders and transient responders showed undetectable, weak, or transient HCV-specific CD8+ T cell responses. (Sustained responders vs. transient and nonresponders: Wilcoxon rank-signed test; P &lt; .01). In conclusion, our data indicate that despite immunosuppression, HCV-specific CD8+ T cells are detectable in patients with recurrent HCV infection after OLTx and that a significant, multispecific, and long-lasting HCV-specific CD8+ T cell response contributes to viral elimination.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>1487-96</ArticlePages>
            <ArticleTitle>Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Gruener</LastName>
                    <ForeName>Norbert Hubert</ForeName>
                </Author>
                <Author>
                    <LastName>Jung</LastName>
                    <ForeName>Maria-Christina</ForeName>
                </Author>
                <Author>
                    <LastName>Ulsenheimer</LastName>
                    <ForeName>Axel</ForeName>
                </Author>
                <Author>
                    <LastName>Gerlach</LastName>
                    <ForeName>Joern Tilman</ForeName>
                </Author>
                <Author>
                    <LastName>Zachoval</LastName>
                    <ForeName>Reinhart</ForeName>
                </Author>
                <Author>
                    <LastName>Diepolder</LastName>
                    <ForeName>Helmut Michael</ForeName>
                </Author>
                <Author>
                    <LastName>Baretton</LastName>
                    <ForeName>Gustavo</ForeName>
                </Author>
                <Author>
                    <LastName>Schauer</LastName>
                    <ForeName>Rolf</ForeName>
                </Author>
                <Author>
                    <LastName>Pape</LastName>
                    <ForeName>Gerd Rudolf</ForeName>
                </Author>
                <Author>
                    <LastName>Schirren</LastName>
                    <ForeName>Carl Albrecht</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany.</Affiliations>
            <ArticleChemicalList>Antiviral Agents;Interferon alpha-2;Interferon-alpha;Recombinant Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adult; Antiviral Agents(therapeutic use); CD8-Positive T-Lymphocytes(immunology); Female; Follow-Up Studies; Hepacivirus(immunology); Hepatitis C(drug therapy; virology); Humans; Interferon alpha-2; Interferon-alpha(therapeutic use); Liver Transplantation(immunology); Male; Middle Aged; Postoperative Period; Recombinant Proteins; Recurrence; Treatment Outcome</ArticleMeshHeadingsList>
            <Journal>
                <Volume>10</Volume>
                <Issue>12</Issue>
                <Title>Liver transplantation :  official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.</Title>
                <Issn>1527-6473</Issn>
                <MedlineTa>Liver Transpl</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HCV Core 35-44</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YLLPRRGPRL</LinearSequence>
                        <StartingPosition>35</StartingPosition>
                        <EndingPosition>44</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>74798</EpitopeId>
                <ReferenceStartingPosition>35</ReferenceStartingPosition>
                <ReferenceEndingPosition>44</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17596</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>YLLPRRGPRL</LinearSequence>
                                            <StartingPosition>35</StartingPosition>
                                            <EndingPosition>44</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 35-44</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YLLPRRGPRL</LinearSequence>
                                        <StartingPosition>35</StartingPosition>
                                        <EndingPosition>44</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, 0 were positive after month 4.  Of the 5 non-responders/relapsers, 1 was positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV Core 131-140</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ADLMGYIPLV</LinearSequence>
                        <StartingPosition>131</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>716</EpitopeId>
                <ReferenceStartingPosition>131</ReferenceStartingPosition>
                <ReferenceEndingPosition>140</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17597</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ADLMGYIPLV</LinearSequence>
                                            <StartingPosition>131</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 131-140</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ADLMGYIPLV</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 3 were positive at the conclusion of treatment, 3 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV Core 178-187</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLALLSCLTV</LinearSequence>
                        <StartingPosition>178</StartingPosition>
                        <EndingPosition>187</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAY82030.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>37097</EpitopeId>
                <ReferenceStartingPosition>178</ReferenceStartingPosition>
                <ReferenceEndingPosition>187</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17598</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLALLSCLTV</LinearSequence>
                                            <StartingPosition>178</StartingPosition>
                                            <EndingPosition>187</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAY82030.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 178-187</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLALLSCLTV</LinearSequence>
                                        <StartingPosition>178</StartingPosition>
                                        <EndingPosition>187</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAY82030.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows: Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 2 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 0 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS2 1073-1081</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CINGVCWTV</LinearSequence>
                        <StartingPosition>1073</StartingPosition>
                        <EndingPosition>1081</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>6435</EpitopeId>
                <ReferenceStartingPosition>1073</ReferenceStartingPosition>
                <ReferenceEndingPosition>1081</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17600</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CINGVCWTV</LinearSequence>
                                            <StartingPosition>1073</StartingPosition>
                                            <EndingPosition>1081</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS2 1073-1081</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CINGVCWTV</LinearSequence>
                                        <StartingPosition>1073</StartingPosition>
                                        <EndingPosition>1081</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, 2 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 0 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS3 1169-1177</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLCPAGHAV</LinearSequence>
                        <StartingPosition>1169</StartingPosition>
                        <EndingPosition>1177</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAY82030.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>37127</EpitopeId>
                <ReferenceStartingPosition>1169</ReferenceStartingPosition>
                <ReferenceEndingPosition>1177</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17613</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLCPAGHAV</LinearSequence>
                                            <StartingPosition>1169</StartingPosition>
                                            <EndingPosition>1177</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAY82030.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS3 1169-1177</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLCPAGHAV</LinearSequence>
                                        <StartingPosition>1169</StartingPosition>
                                        <EndingPosition>1177</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAY82030.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS3 1287-1296</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGAPVTYSTY</LinearSequence>
                        <StartingPosition>1287</StartingPosition>
                        <EndingPosition>1296</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26663.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11105</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>63784</EpitopeId>
                <ReferenceStartingPosition>1287</ReferenceStartingPosition>
                <ReferenceEndingPosition>1293</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17619</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11105</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TGAPVTYSTY</LinearSequence>
                                            <StartingPosition>1287</StartingPosition>
                                            <EndingPosition>1296</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26663.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11105</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS3 1287-1296</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TGAPVTYSTY</LinearSequence>
                                        <StartingPosition>1287</StartingPosition>
                                        <EndingPosition>1296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26663.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11105</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 2 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS3 1406-1415</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KLVALGINAV</LinearSequence>
                        <StartingPosition>1406</StartingPosition>
                        <EndingPosition>1415</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAY82030.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32208</EpitopeId>
                <ReferenceStartingPosition>1406</ReferenceStartingPosition>
                <ReferenceEndingPosition>1415</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17628</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLVALGINAV</LinearSequence>
                                            <StartingPosition>1406</StartingPosition>
                                            <EndingPosition>1415</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAY82030.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS3 1406-1415</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KLVALGINAV</LinearSequence>
                                        <StartingPosition>1406</StartingPosition>
                                        <EndingPosition>1415</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAY82030.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 3 were positive after month 4.  Of the 5 non-responders/relapsers, 2 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS4 1789-1797</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLMAFTAAV</LinearSequence>
                        <StartingPosition>1789</StartingPosition>
                        <EndingPosition>1797</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45534.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>59336</EpitopeId>
                <ReferenceStartingPosition>1789</ReferenceStartingPosition>
                <ReferenceEndingPosition>1797</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17632</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLMAFTAAV</LinearSequence>
                                            <StartingPosition>1789</StartingPosition>
                                            <EndingPosition>1797</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45534.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS4 1789-1797</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLMAFTAAV</LinearSequence>
                                        <StartingPosition>1789</StartingPosition>
                                        <EndingPosition>1797</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45534.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 3 were positive after month 4.  Of the 5 non-responders/relapsers, 2 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS4 1807-1816</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLFNILGGWV</LinearSequence>
                        <StartingPosition>1807</StartingPosition>
                        <EndingPosition>1816</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>37286</EpitopeId>
                <ReferenceStartingPosition>1807</ReferenceStartingPosition>
                <ReferenceEndingPosition>1816</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17633</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LLFNILGGWV</LinearSequence>
                                            <StartingPosition>1807</StartingPosition>
                                            <EndingPosition>1816</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS4 1807-1816</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LLFNILGGWV</LinearSequence>
                                        <StartingPosition>1807</StartingPosition>
                                        <EndingPosition>1816</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 3 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS4B 1851-1859</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILAGYGAGV</LinearSequence>
                        <StartingPosition>1851</StartingPosition>
                        <EndingPosition>1859</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45676.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>26954</EpitopeId>
                <ReferenceStartingPosition>1851</ReferenceStartingPosition>
                <ReferenceEndingPosition>1859</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17634</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILAGYGAGV</LinearSequence>
                                            <StartingPosition>1851</StartingPosition>
                                            <EndingPosition>1859</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45676.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS4B 1851-1859</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILAGYGAGV</LinearSequence>
                                        <StartingPosition>1851</StartingPosition>
                                        <EndingPosition>1859</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45676.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 2 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS5 2252-2260</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILDSFDPLV</LinearSequence>
                        <StartingPosition>2252</StartingPosition>
                        <EndingPosition>2260</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45534.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27011</EpitopeId>
                <ReferenceStartingPosition>2252</ReferenceStartingPosition>
                <ReferenceEndingPosition>2260</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17646</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILDSFDPLV</LinearSequence>
                                            <StartingPosition>2252</StartingPosition>
                                            <EndingPosition>2260</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45534.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS5 2252-2260</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILDSFDPLV</LinearSequence>
                                        <StartingPosition>2252</StartingPosition>
                                        <EndingPosition>2260</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45534.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 2 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS5B 2578-2587</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RLIVFPDLGV</LinearSequence>
                        <StartingPosition>2577</StartingPosition>
                        <EndingPosition>2586</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>54605</EpitopeId>
                <ReferenceStartingPosition>2578</ReferenceStartingPosition>
                <ReferenceEndingPosition>2587</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17647</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RLIVFPDLGV</LinearSequence>
                                            <StartingPosition>2577</StartingPosition>
                                            <EndingPosition>2586</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS5B 2578-2587</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RLIVFPDLGV</LinearSequence>
                                        <StartingPosition>2577</StartingPosition>
                                        <EndingPosition>2586</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows: Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 0 was positive at month 4 post-treatment, 3 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS5B 2727-2735</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GLQDCTMLV</LinearSequence>
                        <StartingPosition>2727</StartingPosition>
                        <EndingPosition>2735</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45534.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>21079</EpitopeId>
                <ReferenceStartingPosition>2727</ReferenceStartingPosition>
                <ReferenceEndingPosition>2735</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17649</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GLQDCTMLV</LinearSequence>
                                            <StartingPosition>2727</StartingPosition>
                                            <EndingPosition>2735</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45534.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS5B 2727-2735</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GLQDCTMLV</LinearSequence>
                                        <StartingPosition>2727</StartingPosition>
                                        <EndingPosition>2735</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45534.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, 4 were positive after month 4.  Of the 5 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV E1 220-227</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILHTPGCV</LinearSequence>
                        <StartingPosition>220</StartingPosition>
                        <EndingPosition>227</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P27958.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11108</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27096</EpitopeId>
                <ReferenceStartingPosition>220</ReferenceStartingPosition>
                <ReferenceEndingPosition>227</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17652</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ILHTPGCV</LinearSequence>
                                            <StartingPosition>220</StartingPosition>
                                            <EndingPosition>227</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P27958.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV E1 220-227</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ILHTPGCV</LinearSequence>
                                        <StartingPosition>220</StartingPosition>
                                        <EndingPosition>227</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P27958.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11108</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured.  There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV E1 257-266</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QLRRIDLLV</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279960</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>51528</EpitopeId>
                <ReferenceStartingPosition>257</ReferenceStartingPosition>
                <ReferenceEndingPosition>266</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17655</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QLRRIDLLV</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279960</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV E1 257-266</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QLRRIDLLV</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279960</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 2 were positive at month 4 post-treatment, 4 were positive after month 4.  Of the 5 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV E1 363-371</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SMVGNWAKV</LinearSequence>
                        <StartingPosition>363</StartingPosition>
                        <EndingPosition>371</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P27958.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11108</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>59766</EpitopeId>
                <ReferenceStartingPosition>363</ReferenceStartingPosition>
                <ReferenceEndingPosition>371</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17657</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SMVGNWAKV</LinearSequence>
                                            <StartingPosition>363</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P27958.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV E1 363-371</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SMVGNWAKV</LinearSequence>
                                        <StartingPosition>363</StartingPosition>
                                        <EndingPosition>371</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P27958.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11108</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 5 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV E2 401-411</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SLLAPGAKQNV</LinearSequence>
                        <StartingPosition>401</StartingPosition>
                        <EndingPosition>411</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA45676.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>59240</EpitopeId>
                <ReferenceStartingPosition>401</ReferenceStartingPosition>
                <ReferenceEndingPosition>411</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17658</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SLLAPGAKQNV</LinearSequence>
                                            <StartingPosition>401</StartingPosition>
                                            <EndingPosition>411</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA45676.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV E2 401-411</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SLLAPGAKQNV</LinearSequence>
                                        <StartingPosition>401</StartingPosition>
                                        <EndingPosition>411</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA45676.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 5 HLA-matched sustained responders, 2 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 0 were positive after month 4.  Of the 5 non-responders/relapsers, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS5 2588-2596</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RVCEKMALY</LinearSequence>
                        <StartingPosition>2587</StartingPosition>
                        <EndingPosition>2595</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>56247</EpitopeId>
                <ReferenceStartingPosition>2588</ReferenceStartingPosition>
                <ReferenceEndingPosition>2596</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17680</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>RVCEKMALY</LinearSequence>
                                            <StartingPosition>2587</StartingPosition>
                                            <EndingPosition>2595</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>242</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS5 2588-2596</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>RVCEKMALY</LinearSequence>
                                        <StartingPosition>2587</StartingPosition>
                                        <EndingPosition>2595</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 1 HLA-matched sustained responder, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 1 was positive after month 4.  Of the 3 non-responders/relapsers, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV NS5B 2794-2802</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HDGAGKRVY</LinearSequence>
                        <StartingPosition>2794</StartingPosition>
                        <EndingPosition>2802</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P27958.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11108</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>23619</EpitopeId>
                <ReferenceStartingPosition>2794</ReferenceStartingPosition>
                <ReferenceEndingPosition>2802</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17682</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HDGAGKRVY</LinearSequence>
                                            <StartingPosition>2794</StartingPosition>
                                            <EndingPosition>2802</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P27958.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11108</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>242</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV NS5B 2794-2802</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HDGAGKRVY</LinearSequence>
                                        <StartingPosition>2794</StartingPosition>
                                        <EndingPosition>2802</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P27958.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11108</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 1 HLA-matched sustained responder, 1 was positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 0 were positive after month 4.  Of the 3 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV Core 41-49</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPRLGFRAT</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279960</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>21754</EpitopeId>
                <ReferenceStartingPosition>41</ReferenceStartingPosition>
                <ReferenceEndingPosition>49</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17683</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GPRLGFRAT</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279960</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 41-49</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GPRLGFRAT</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279960</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 3 HLA-matched sustained responders, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 1 non-responder/relapser, 0 were positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 were positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV Core 111-119</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DPRRRSRNL</LinearSequence>
                        <StartingPosition>111</StartingPosition>
                        <EndingPosition>119</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P29846.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>9746</EpitopeId>
                <ReferenceStartingPosition>111</ReferenceStartingPosition>
                <ReferenceEndingPosition>119</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17685</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DPRRRSRNL</LinearSequence>
                                            <StartingPosition>111</StartingPosition>
                                            <EndingPosition>119</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P29846.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>300</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 111-119</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DPRRRSRNL</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>119</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P29846.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>4</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 3 HLA-matched sustained responders, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, 0 were positive after month 4.  Of the 1 non-responder/relapser, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 1 was positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV E1 235-242</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASRCWVAM</LinearSequence>
                        <StartingPosition>235</StartingPosition>
                        <EndingPosition>242</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAY82034.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>41856</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>4735</EpitopeId>
                <ReferenceStartingPosition>235</ReferenceStartingPosition>
                <ReferenceEndingPosition>242</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17686</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASRCWVAM</LinearSequence>
                                            <StartingPosition>235</StartingPosition>
                                            <EndingPosition>242</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAY82034.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>41856</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>281</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV E1 235-242</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASRCWVAM</LinearSequence>
                                        <StartingPosition>235</StartingPosition>
                                        <EndingPosition>242</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAY82034.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>41856</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, and the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 1 HLA-matched sustained responder, donor not tested at the conclusion of treatment, 0 were positive at month 4 post-treatment, 0 were positive after month 4.  Of the 2 non-responders/relapsers, 1 was positive at the conclusion of treatment, 1 was positive at month 4 post-treatment, and 0 was positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>HCV Core 88-96</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NEGLGWAGW</LinearSequence>
                        <StartingPosition>88</StartingPosition>
                        <EndingPosition>96</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P26660.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11113</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>43624</EpitopeId>
                <ReferenceStartingPosition>88</ReferenceStartingPosition>
                <ReferenceEndingPosition>96</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 2 and 3</LocationOfData>
                        <TCellId>17687</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:1883</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11113</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>T cell CD8+</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NEGLGWAGW</LinearSequence>
                                            <StartingPosition>88</StartingPosition>
                                            <EndingPosition>96</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P26660.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11113</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Purified CD8+ cells were stimulated with autologous PBMCs and peptide for 5 days.  Restimulation was performed on day 12 with autologous PBMCs and cultured until proliferation stopped (approximately 5 weeks).</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>286</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HCV Core 88-96</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NEGLGWAGW</LinearSequence>
                                        <StartingPosition>88</StartingPosition>
                                        <EndingPosition>96</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P26660.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11113</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>48</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <AssayComments>IFN-γ release from CD8+ cells derived from blood and liver was measured. There were two patient groups (sustained responders and non-responders/relapsers) monitored before, at the end of, and up to year post-IFN-γ treatment after orthoptic liver transplant.  PBMC responses to this epitope were as follows:  Of 1 HLA-matched sustained responder, 1 was positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, 1 was positive after month 4.  Of the 1 non-responder/relapser, 0 were positive at the conclusion of treatment, 0 were positive at month 4 post-treatment, and 1 was positive after month 4.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

